Valeant revenue forecast misses estimates as competition heats up

(Reuters) - Valeant Pharmaceuticals' forecast for 2018 revenue fell below Wall Street estimates, as the company faces intensifying competition for some of its major products.

from Reuters: Business News http://ift.tt/2F2iMA5